Top

Journal of Neurology

Published in:

01-12-2017 | Letter to the Editors

Reversible amygdala enlargement: a longitudinal observation of a patient with elderly onset temporal lobe epilepsy

Authors: Takashi Matsudaira, Yoshio Omote, Tatsuhiro Terada, Akihiko Kondo, Tomokazu Obi, Yasuomi Ouchi, Yushi Inoue

Published in: Journal of Neurology | Issue 12/2017

Excerpt

Dear Sirs, …

Minami N, Morino M, Uda T et al (2015) Surgery for amygdala enlargement with mesial temporal lobe epilepsy: pathological findings and seizure outcome. J Neurol Neurosurg Psychiatry 86:887–894. doi:10.1136/jnnp-2014-308383 CrossRefPubMed

Kim DW, Lee SK, Chung CK et al (2012) Clinical features and pathological characteristics of amygdala enlargement in mesial temporal lobe epilepsy. J Clin Neurosci 19:509–512. doi:10.1016/j.jocn.2011.05.042 CrossRefPubMed

Malter MP, Widman G, Galldiks N et al (2016) Suspected new-onset autoimmune temporal lobe epilepsy with amygdala enlargement. Epilepsia 57:1485–1494. doi:10.1111/epi.13471 CrossRefPubMed

FreeSurfer (2013) http://surfer.nmr.mgh.harvard.edu. Accessed 9 July 2017

Matsuda H, Matsuda K, Nakamura F et al (2009) Contribution of subtraction ictal SPECT coregistered to MRI to epilepsy surgery: a multicenter study. Ann Nucl Med 23:283–291. doi:10.1007/s12149-009-0236-6 CrossRefPubMed

Malter MP, Helmstaedter C, Urbach H et al (2010) Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 67:470–478. doi:10.1002/ana.21917 CrossRefPubMed

Briellmann RS, Wellard RM, Jackson GD (2005) Seizure-associated abnormalities in epilepsy: evidence from MR imaging. Epilepsia 46:760–766CrossRefPubMed

Guye M, Régis J, Tamura M et al (2006) The role of corticothalamic coupling in human temporal lobe epilepsy. Brain 129:1917–1928CrossRefPubMed

Vossel KA, Beagle AJ, Rabinovici GD et al (2013) Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol 70:1158–1166. doi:10.1001/jamaneurol.2013.136 CrossRefPubMedPubMedCentral

10.

Vossel KA, Tartaglia MC, Nygaard HB et al (2017) Epileptic activity in Alzheimer’s disease: causes and clinical relevance. Lancet Neurol 16:311–322. doi:10.1016/S1474-4422(17)30044-3 CrossRefPubMed

11.

Noebels J (2011) A perfect storm: converging paths of epilepsy and Alzheimer’s dementia intersect in the hippocampal formation. Epilepsia 52:39–46. doi:10.1111/j.1528-1167.2010.02909.x CrossRefPubMedPubMedCentral

12.

Harper L, Barkhof F, Fox NC et al (2015) Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales. J Neurol Neurosurg Psychiatry 86:1225–1233. doi:10.1136/jnnp-2014-310090 CrossRefPubMed

13.

Wahlund LO, Julin P, Johansson SE et al (2000) Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. J Neurol Neurosurg Psychiatry 69:630–635CrossRefPubMedPubMedCentral

Title: Reversible amygdala enlargement: a longitudinal observation of a patient with elderly onset temporal lobe epilepsy
Authors: Takashi Matsudaira
Yoshio Omote
Tatsuhiro Terada
Akihiko Kondo
Tomokazu Obi
Yasuomi Ouchi
Yushi Inoue
Publication date: 01-12-2017
Publisher: Springer Berlin Heidelberg
Published in: Journal of Neurology / Issue 12/2017
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-017-8649-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Reversible amygdala enlargement: a longitudinal observation of a patient with elderly onset temporal lobe epilepsy

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2017

A novel mutation of VAPB in one Chinese familial amyotrophic lateral sclerosis pedigree and its clinical characteristics

Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study

Treatment outcome in patients with clinically defined carpal tunnel syndrome but normal electrodiagnostic test results: a randomized controlled trial

The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)

Prevalence and clinical characteristics of cortical superficial siderosis in patients with acute stroke